{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:29:39Z","timestamp":1793230179557,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/18\/15\/33566"],"award-info":[{"award-number":["PG\/18\/15\/33566"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","award":["Imperial College European Partners Fund 2018"],"award-info":[{"award-number":["Imperial College European Partners Fund 2018"]}],"id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","award":["PRA_2018_20"],"award-info":[{"award-number":["PRA_2018_20"]}],"id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>ADAMTS-5 is a major protease involved in the turnover of proteoglycans such as aggrecan and versican. Dysregulated aggrecanase activity of ADAMTS-5 has been directly linked to the etiology of osteoarthritis (OA). For this reason, ADAMTS-5 is a pharmaceutical target for the treatment of OA. ADAMTS-5 shares high structural and functional similarities with ADAMTS-4, which makes the design of selective inhibitors particularly challenging. Here we exploited the ADAMTS-5 binding capacity of \u03b2-<jats:italic>N<\/jats:italic>-acetyl-<jats:sc>d<\/jats:sc>-glucosamine to design a new class of sugar-based arylsulfonamides. Our most promising compound, <jats:bold>4b<\/jats:bold>, is a non-zinc binding ADAMTS-5 inhibitor which showed high selectivity over ADAMTS-4. Docking calculations combined with molecular dynamics simulations demonstrated that <jats:bold>4b<\/jats:bold> is a cross-domain inhibitor that targets the interface of the metalloproteinase and disintegrin-like domains. Furthermore, the interaction between <jats:bold>4b<\/jats:bold> and the ADAMTS-5 Dis domain is mediated by hydrogen bonds between the sugar moiety and two lysine residues (K532 and K533). Targeted mutagenesis of these two residues confirmed their importance both for versicanase activity and inhibitor binding. This positively-charged cluster of ADAMTS-5 represents a previously unknown substrate-binding site (exosite) which is critical for substrate recognition and can therefore be targeted for the development of selective ADAMTS-5 inhibitors.<\/jats:p>","DOI":"10.1038\/s41598-020-80294-1","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:26:43Z","timestamp":1610537203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide"],"prefix":"10.1038","volume":"11","author":[{"given":"Salvatore","family":"Santamaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doretta","family":"Cuffaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Liva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rens","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Rossello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Ahnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"80294_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.cr.7290106","volume":"12","author":"C Kiani","year":"2002","unstructured":"Kiani, C., Chen, L., Wu, Y. J., Yee, A. J. & Yang, B. B. Structure and function of aggrecan. Cell Res. 12, 19\u201332 (2002).","journal-title":"Cell Res."},{"key":"80294_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.matbio.2018.02.019","volume":"71\u201372","author":"TN Wight","year":"2018","unstructured":"Wight, T. N. A role for proteoglycans in vascular disease. Matrix Biol. 71\u201372, 396\u2013420 (2018).","journal-title":"Matrix Biol."},{"key":"80294_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrrheum.2010.198","volume":"7","author":"D Heineg\u00e5rd","year":"2011","unstructured":"Heineg\u00e5rd, D. & Saxne, T. The role of the cartilage matrix in osteoarthritis. Nat. Rev. Rheumatol. 7, 50\u201356 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"80294_CR4","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1074\/jbc.M708647200","volume":"283","author":"K Fushimi","year":"2008","unstructured":"Fushimi, K., Troeberg, L., Nakamura, H., Lim, N. H. & Nagase, H. Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity. J. Biol. Chem. 283, 6706\u20136716 (2008).","journal-title":"J. Biol. Chem."},{"key":"80294_CR5","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1038\/s41598-019-47494-w","volume":"9","author":"S Santamaria","year":"2019","unstructured":"Santamaria, S. et al. Exosites in hypervariable loops of ADAMTS spacer domains control substrate recognition and proteolysis. Sci. Rep. 9, 10914 (2019).","journal-title":"Sci. Rep."},{"key":"80294_CR6","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1002\/art.20558","volume":"50","author":"SS Glasson","year":"2004","unstructured":"Glasson, S. S. et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 50, 2547\u201325458 (2004).","journal-title":"Arthritis Rheum."},{"key":"80294_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nature03369","volume":"434","author":"SS Glasson","year":"2005","unstructured":"Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644\u2013648 (2005).","journal-title":"Nature"},{"key":"80294_CR8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature03417","volume":"434","author":"H Stanton","year":"2005","unstructured":"Stanton, H. et al. ADAMTS-5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648\u2013652 (2005).","journal-title":"Nature"},{"key":"80294_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1042\/BJ20150758","volume":"471","author":"S Santamaria","year":"2015","unstructured":"Santamaria, S. et al. Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2). Biochem J. 471, 391\u2013401 (2015).","journal-title":"Biochem J."},{"key":"80294_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.joca.2015.02.778","volume":"23","author":"J Larkin","year":"2015","unstructured":"Larkin, J. et al. Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification. Osteoarthr. Cartil. 23, 1254\u20131266 (2015).","journal-title":"Osteoarthr. Cartil."},{"key":"80294_CR11","doi-asserted-by":"publisher","first-page":"18294","DOI":"10.1074\/jbc.M701523200","volume":"282","author":"C Gendron","year":"2007","unstructured":"Gendron, C. et al. Proteolytic activities of Human ADAMTS-5. Comparative studies with ADAMTS-4. J. Biol. Chem. 282, 18294\u201318306 (2007).","journal-title":"J. Biol. Chem."},{"key":"80294_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1074\/jbc.M705879200","volume":"283","author":"HS Shieh","year":"2008","unstructured":"Shieh, H. S. et al. High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2). J. Biol. Chem. 283, 1501\u20131507 (2008).","journal-title":"J. Biol. Chem."},{"key":"80294_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1110\/ps.073287008","volume":"17","author":"L Mosyak","year":"2008","unstructured":"Mosyak, L. et al. Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5. Protein Sci. 17, 16\u201321 (2008).","journal-title":"Protein Sci."},{"key":"80294_CR14","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.4155\/fmc.14.84","volume":"6","author":"J El Bakali","year":"2014","unstructured":"El Bakali, J. et al. Inhibition of aggrecanases as a therapeutic strategy in osteoarthritis. Future Med. Chem. 6, 1399\u201313412 (2014).","journal-title":"Future Med. Chem."},{"key":"80294_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/bph.14186","volume":"176","author":"S Santamaria","year":"2019","unstructured":"Santamaria, S. & de Groot, R. Monoclonal antibodies against metzincin targets. Br. J. Pharmacol. 176, 52\u201366 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"80294_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nbt1273","volume":"25","author":"AC Cheng","year":"2007","unstructured":"Cheng, A. C. et al. Structure-based maximal affinity model predicts small-molecule druggability. Nat. Biotechnol. 25, 71\u201375 (2007).","journal-title":"Nat. Biotechnol."},{"key":"80294_CR17","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1096\/fj.08-112680","volume":"22","author":"L Troeberg","year":"2008","unstructured":"Troeberg, L. et al. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J. 22, 3515\u20133524 (2008).","journal-title":"FASEB J."},{"key":"80294_CR18","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1182\/blood-2007-10-120543","volume":"111","author":"MA Crowther","year":"2008","unstructured":"Crowther, M. A. & Warkentin, T. E. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood 111, 4871\u20134879 (2008).","journal-title":"Blood"},{"key":"80294_CR19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","volume":"32","author":"TE Warkentin","year":"1995","unstructured":"Warkentin, T. E. et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N. Engl. J. Med. 32, 1330\u20131335 (1995).","journal-title":"N. Engl. J. Med."},{"key":"80294_CR20","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/cmdc.201600235","volume":"11","author":"E Nuti","year":"2016","unstructured":"Nuti, E. et al. Sugar-based arylsulfonamide carboxylates as selective and water-soluble matrix metalloproteinase-12 inhibitors. Chem. Med. Chem. 11, 1626\u20131637 (2016).","journal-title":"Chem. Med. Chem."},{"key":"80294_CR21","doi-asserted-by":"publisher","first-page":"27859","DOI":"10.1074\/jbc.M114.573287","volume":"289","author":"SJ Foulcer","year":"2014","unstructured":"Foulcer, S. J. et al. Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5. J. Biol. Chem. 289, 27859\u201327873 (2014).","journal-title":"J. Biol. Chem."},{"key":"80294_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejmech.2012.12.058","volume":"62","author":"E Nuti","year":"2013","unstructured":"Nuti, E. et al. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation. Eur. J. Med. Chem. 62, 379\u2013394 (2013).","journal-title":"Eur. J. Med. Chem."},{"key":"80294_CR23","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI30765","volume":"117","author":"CB Little","year":"2007","unstructured":"Little, C. B. et al. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J. Clin. Invest. 117, 1627\u20131636 (2007).","journal-title":"J. Clin. Invest."},{"key":"80294_CR24","doi-asserted-by":"publisher","first-page":"10000","DOI":"10.1073\/pnas.0402784101","volume":"101","author":"A Saghatelian","year":"2004","unstructured":"Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M. & Cravatt, B. F. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl. Acad. Sci. U. S. A. 101, 10000\u201310005 (2004).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"80294_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/iep.12344","author":"S Santamaria","year":"2020","unstructured":"Santamaria, S. ADAMTS-5: a difficult teenager turning 20. Int. J. Exp. Pathol. https:\/\/doi.org\/10.1111\/iep.12344 (2020).","journal-title":"Int. J. Exp. Pathol."},{"key":"80294_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/cmdc.201402478","volume":"10","author":"J Lanz","year":"2015","unstructured":"Lanz, J. & Riedl, R. Merging allosteric and active site binding motifs: de novo generation of target selectivity and potency via natural-product-derived fragments. Chem. Med. Chem. 10, 451\u2013454 (2015).","journal-title":"Chem. Med. Chem."},{"key":"80294_CR27","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1016\/S0960-894X(03)00531-6","volume":"13","author":"T Tsukida","year":"2003","unstructured":"Tsukida, T., Inoue, Y., Kondo, H., Yoshino, K. & Nishimura, S. Design, synthesis and evaluation of novel azasugar-based MMP\/ADAM inhibitors. Biorg. Med. Chem. Lett. 13, 2741\u20132744 (2003).","journal-title":"Biorg. Med. Chem. Lett."},{"key":"80294_CR28","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1016\/j.ejmech.2010.09.057","volume":"45","author":"E Attolino","year":"2010","unstructured":"Attolino, E. et al. Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs). Eur. J. Med. Chem. 45, 5919\u20135925 (2010).","journal-title":"Eur. J. Med. Chem."},{"key":"80294_CR29","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1016\/j.bmc.2018.10.024","volume":"26","author":"D Cuffaro","year":"2018","unstructured":"Cuffaro, D. et al. Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates. Bioorg. Med. Chem. 26, 5804\u20135815 (2018).","journal-title":"Bioorg. Med. Chem."},{"key":"80294_CR30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/cmdc.200600020","volume":"1","author":"V Calderone","year":"2006","unstructured":"Calderone, V. et al. A high-affinity carbohydrate-containing inhibitor of matrix metalloproteinases. Chem. Med. Chem. 1, 598\u2013601 (2006).","journal-title":"Chem. Med. Chem."},{"key":"80294_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jmb.2007.07.047","volume":"373","author":"S Gerhardt","year":"2007","unstructured":"Gerhardt, S. et al. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains. J. Mol. Biol. 373, 891\u2013902 (2007).","journal-title":"J. Mol. Biol."},{"key":"80294_CR32","doi-asserted-by":"publisher","first-page":"19274","DOI":"10.1073\/pnas.0909755106","volume":"106","author":"M Akiyama","year":"2009","unstructured":"Akiyama, M., Takeda, S., Kokame, K., Takagi, J. & Miyata, T. Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. Proc. Natl. Acad. Sci. U. S. A. 106, 19274\u201319279 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"80294_CR33","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1038\/s41467-019-11474-5","volume":"10","author":"A Petri","year":"2019","unstructured":"Petri, A. et al. Crystal structure and substrate-induced activation of ADAMTS13. Nat. Commun. 10, 3781 (2019).","journal-title":"Nat. Commun."},{"key":"80294_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0006-291X(02)00255-3","volume":"293","author":"P Wei","year":"2002","unstructured":"Wei, P. et al. Protein engineering and properties of human metalloproteinase and thrombospondin 1. Biochem. Biophys. Res. Commun. 293, 478\u2013488 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"80294_CR35","doi-asserted-by":"publisher","first-page":"10109","DOI":"10.1074\/jbc.M312123200","volume":"279","author":"M Kashiwagi","year":"2004","unstructured":"Kashiwagi, M. et al. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J. Biol. Chem. 279, 10109\u201310119 (2004).","journal-title":"J. Biol. Chem."},{"key":"80294_CR36","doi-asserted-by":"publisher","first-page":"9503","DOI":"10.1074\/jbc.M211009200","volume":"278","author":"RPT Somerville","year":"2003","unstructured":"Somerville, R. P. T. et al. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J. Biol. Chem. 278, 9503\u20139513 (2003).","journal-title":"J. Biol. Chem."},{"key":"80294_CR37","doi-asserted-by":"publisher","first-page":"29428","DOI":"10.1074\/jbc.M505513200","volume":"280","author":"J Ai","year":"2005","unstructured":"Ai, J., Smith, P., Wang, S., Zhang, P. & Zheng, X. L. The proximal carboxylterminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor. J. Biol. Chem. 280, 29428\u201329434 (2005).","journal-title":"J. Biol. Chem."},{"key":"80294_CR38","doi-asserted-by":"publisher","first-page":"19099","DOI":"10.1073\/pnas.0607264104","volume":"103","author":"W Gao","year":"2006","unstructured":"Gao, W., Anderson, P. J., Majerus, E. M., Tuley, E. A. & Sadler, J. E. Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease. Proc. Natl. Acad. Sci. U. S. A. 103, 19099\u201319104 (2006).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"80294_CR39","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1182\/blood-2008-11-187914","volume":"113","author":"R de Groot","year":"2009","unstructured":"de Groot, R., Bardhan, A., Ramroop, N., Lane, D. A. & Crawley, J. T. Essential role of the disintegrinlike domain in ADAMTS13 function. Blood 113, 5609\u20135616 (2009).","journal-title":"Blood"},{"key":"80294_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2009.07.005","volume":"28","author":"L Troeberg","year":"2009","unstructured":"Troeberg, L. et al. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. Matrix Biol. 28, 463\u2013469 (2009).","journal-title":"Matrix Biol."},{"key":"80294_CR41","doi-asserted-by":"publisher","first-page":"13912","DOI":"10.1074\/jbc.273.22.13912","volume":"273","author":"K Kuno","year":"1998","unstructured":"Kuno, K. & Matsushima, K. ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type I motifs and its spacing region. J. Biol. Chem. 273, 13912\u201313917 (1998).","journal-title":"J. Biol. Chem."},{"key":"80294_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0076-6879(95)48008-0","volume":"248","author":"CG Knight","year":"1995","unstructured":"Knight, C. G. Active-site titration of peptidases. Methods Enzymol. 248, 85\u2013101 (1995).","journal-title":"Methods Enzymol."},{"key":"80294_CR43","volume-title":"Assay Guidance Manual","author":"DS Auld","year":"2017","unstructured":"Auld, D. S., Inglese, J. & Dahlin, J. L. Assay interference by aggregation. In Assay Guidance Manual (eds Markossian, S. et al.) (Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, 2017)."},{"key":"80294_CR44","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1074\/jbc.M508316200","volume":"281","author":"S Zanardelli","year":"2006","unstructured":"Zanardelli, S. et al. ADAMTS13 substrate recognition of von Willebrand factor A2 domain. J. Biol. Chem. 281, 1555\u20131563 (2006).","journal-title":"J. Biol. Chem."},{"key":"80294_CR45","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3109\/14756366.2014.1000889","volume":"30","author":"S Santamaria","year":"2015","unstructured":"Santamaria, S. et al. Kinetic characterization of 4,4\u2019-biphenylsulfonamides as selective non-zinc binding MMP inhibitors. J. Enzyme Inhib. Med. Chem. 30, 947\u2013954 (2015).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"80294_CR46","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"80294_CR47","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1021\/ci500209e","volume":"54","author":"D Santos-Martins","year":"2014","unstructured":"Santos-Martins, D., Forli, S., Ramos, M. J. & Olson, A. J. AutoDock4Zn: an improved AutoDock force field for small-molecule docking to zinc metalloproteins. J. Chem. Inf. Model. 54, 2371\u20132379 (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"80294_CR48","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1021\/acs.jnatprod.6b00484","volume":"79","author":"L Milella","year":"2016","unstructured":"Milella, L. et al. \u03b1-Glucosidase and \u03b1-amylase Inhibitors from Arcytophyllum thymifolium. J. Nat. Prod. 79, 2104\u20132112 (2016).","journal-title":"J. Nat. Prod."},{"key":"80294_CR49","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1021\/acs.jnatprod.6b00627","volume":"79","author":"F Dal Piaz","year":"2016","unstructured":"Dal Piaz, F. et al. Drug affinity responsive target stability (DARTS) identifies laurifolioside as a new clathrin heavy chain modulator. J. Nat. Prod. 79, 2681\u20132692 (2016).","journal-title":"J. Nat. Prod."},{"key":"80294_CR50","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ejmech.2018.08.038","volume":"157","author":"G Bononi","year":"2018","unstructured":"Bononi, G. et al. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors. Eur. J. Med. Chem. 157, 817\u2013836 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"80294_CR51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1021\/ci6004383","volume":"47","author":"T Tuccinardi","year":"2007","unstructured":"Tuccinardi, T., Manetti, F., Schenone, S., Martinelli, A. & Botta, M. Construction and validation of a RET TK catalytic domain by homology modeling. J. Chem. Inf. Model. 47, 644\u2013655 (2007).","journal-title":"J. Chem. Inf. Model."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80294-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80294-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80294-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:00:40Z","timestamp":1670032840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80294-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80294"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80294-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"949"}}